A regional corner of Africa is a hotspot for cases of HIV, tuberculosis and malaria, prompting researchers to call for targeted health support rather than a national response. The new research, published in BMJ Global...
Chasing India’s target of eliminating tuberculosis by 2025, scientists at the Indian Council of Medical Research have recruited about 12,000 participants for a phase III study of two potential vaccines. The researchers...
Globally, an estimated 10 million people develop tuberculosis (TB) each year and the disease remains a leading cause of death from a single infectious agent. Standard short-course anti-TB treatment still requires a...
A tuberculosis vaccine developed 100 years ago also makes vaccinated persons less susceptible to other infections. While this effect has been recognized for a long time, it is not known what causes it. Together with...
The origins of vaccines go back to the turn of the 19th century when Edward Jenner noticed that dairymaids who had been previously infected with cowpox were immune to smallpox. From there, he created the first “vaccine”...
An experimental tuberculosis (TB) vaccine could prevent people who have TB with no sign of illness from progressing to TB of the lungs for up to three years, potentially saving millions of lives, a study shows. The WHO...
For years, scientists have been trying to come up with a better way to protect people against tuberculosis, the disease caused by infection with the Mycobacterium tuberculosis (Mtb) bacteria. Texas Biomedical Research...
In a study published in the journal ‘Cell Reports’, the research shows that the broad-spectrum effects of the Bacillus Calmette-Guerin (BCG) vaccine could be mediated by metabolic and epigenetic changes in white blood...
BCG, the only currently approved TB vaccine, has been around for almost a century and is only partially effective. When given to children, BCG is estimated to prevent 20% of infections and to protect half of the...
Doctors Without Borders (MSF) released a new publication of DR-TB Drugs Under the Microscope, showing that just 2 percent out of the 150,000 people with drug-resistant tuberculosis have access to the new, better...